CELLTRION PHARM INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 068760 for the last quarter is 117.15 B KRW, and it's 20.82% higher compared to the previous quarter. The net income of Q2 24 is 5.59 B KRW.